183 related articles for article (PubMed ID: 27734394)
1. Studying the CCN Proteins in Fibrosis.
Hutchenreuther J; Leask A; Thompson K
Methods Mol Biol; 2017; 1489():423-429. PubMed ID: 27734394
[TBL] [Abstract][Full Text] [Related]
2. CCN2 expression by fibroblasts is not required for cutaneous tissue repair.
Liu S; Thompson K; Leask A
Wound Repair Regen; 2014; 22(1):119-24. PubMed ID: 24393160
[TBL] [Abstract][Full Text] [Related]
3. Fibrosis caused by loss of PTEN expression in mouse fibroblasts is crucially dependent on CCN2.
Liu S; Parapuram SK; Leask A
Arthritis Rheum; 2013 Nov; 65(11):2940-4. PubMed ID: 23983074
[TBL] [Abstract][Full Text] [Related]
4. Yin/Yang expression of CCN family members: Transforming growth factor beta 1, via ALK5/FAK/MEK, induces CCN1 and CCN2, yet suppresses CCN3, expression in human dermal fibroblasts.
Peidl A; Perbal B; Leask A
PLoS One; 2019; 14(6):e0218178. PubMed ID: 31170244
[TBL] [Abstract][Full Text] [Related]
5. Loss of PTEN expression by mouse fibroblasts results in lung fibrosis through a CCN2-dependent mechanism.
Parapuram SK; Thompson K; Tsang M; Hutchenreuther J; Bekking C; Liu S; Leask A
Matrix Biol; 2015 Apr; 43():35-41. PubMed ID: 25644104
[TBL] [Abstract][Full Text] [Related]
6. CCN2 in Skin Fibrosis.
Leask A
Methods Mol Biol; 2017; 1489():417-421. PubMed ID: 27734393
[TBL] [Abstract][Full Text] [Related]
7. CCN2 is required for bleomycin-induced skin fibrosis in mice.
Liu S; Shi-wen X; Abraham DJ; Leask A
Arthritis Rheum; 2011 Jan; 63(1):239-46. PubMed ID: 20936632
[TBL] [Abstract][Full Text] [Related]
8. Single-target RNA interference for the blockade of multiple interacting proinflammatory and profibrotic pathways in cardiac fibroblasts.
Tank J; Lindner D; Wang X; Stroux A; Gilke L; Gast M; Zietsch C; Skurk C; Scheibenbogen C; Klingel K; Lassner D; Kühl U; Schultheiss HP; Westermann D; Poller W
J Mol Cell Cardiol; 2014 Jan; 66():141-56. PubMed ID: 24239602
[TBL] [Abstract][Full Text] [Related]
9. Selective expression of connective tissue growth factor in fibroblasts in vivo promotes systemic tissue fibrosis.
Sonnylal S; Shi-Wen X; Leoni P; Naff K; Van Pelt CS; Nakamura H; Leask A; Abraham D; Bou-Gharios G; de Crombrugghe B
Arthritis Rheum; 2010 May; 62(5):1523-32. PubMed ID: 20213804
[TBL] [Abstract][Full Text] [Related]
10. CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous inhibitor of the fibrotic pathway in an in vitro model of renal disease.
Riser BL; Najmabadi F; Perbal B; Peterson DR; Rambow JA; Riser ML; Sukowski E; Yeger H; Riser SC
Am J Pathol; 2009 May; 174(5):1725-34. PubMed ID: 19359517
[TBL] [Abstract][Full Text] [Related]
11. CCN3/NOV small interfering RNA enhances fibrogenic gene expression in primary hepatic stellate cells and cirrhotic fat storing cell line CFSC.
Borkham-Kamphorst E; van Roeyen CR; Van de Leur E; Floege J; Weiskirchen R
J Cell Commun Signal; 2012 Mar; 6(1):11-25. PubMed ID: 21748432
[TBL] [Abstract][Full Text] [Related]
12. CTGF/CCN2 is an autocrine regulator of cardiac fibrosis.
Dorn LE; Petrosino JM; Wright P; Accornero F
J Mol Cell Cardiol; 2018 Aug; 121():205-211. PubMed ID: 30040954
[TBL] [Abstract][Full Text] [Related]
13. CTGF/CCN2 exerts profibrotic action in myoblasts via the up-regulation of sphingosine kinase-1/S1P3 signaling axis: Implications in the action mechanism of TGFβ.
Bruno G; Cencetti F; Pertici I; Japtok L; Bernacchioni C; Donati C; Bruni P
Biochim Biophys Acta; 2015 Feb; 1851(2):194-202. PubMed ID: 25457224
[TBL] [Abstract][Full Text] [Related]
14. Connective tissue growth factor induces renal fibrosis via epidermal growth factor receptor activation.
Rayego-Mateos S; Morgado-Pascual JL; Rodrigues-Diez RR; Rodrigues-Diez R; Falke LL; Mezzano S; Ortiz A; Egido J; Goldschmeding R; Ruiz-Ortega M
J Pathol; 2018 Feb; 244(2):227-241. PubMed ID: 29160908
[TBL] [Abstract][Full Text] [Related]
15. Roles for CCN2 in normal physiological processes.
Hall-Glenn F; Lyons KM
Cell Mol Life Sci; 2011 Oct; 68(19):3209-17. PubMed ID: 21858450
[TBL] [Abstract][Full Text] [Related]
16. CCN2: a novel, specific and valid target for anti-fibrotic drug intervention.
Leask A
Expert Opin Ther Targets; 2013 Sep; 17(9):1067-71. PubMed ID: 23848501
[TBL] [Abstract][Full Text] [Related]
17. Protocol for CRISPR/Cas Genome Editing for Investigating Cell Communication Network.
Okusha Y; Eguchi T
Methods Mol Biol; 2023; 2582():157-167. PubMed ID: 36370349
[TBL] [Abstract][Full Text] [Related]
18. Fell-Muir lecture: Connective tissue growth factor (CCN2) -- a pernicious and pleiotropic player in the development of kidney fibrosis.
Mason RM
Int J Exp Pathol; 2013 Feb; 94(1):1-16. PubMed ID: 23110747
[TBL] [Abstract][Full Text] [Related]
19. Genetic Analysis of Connective Tissue Growth Factor as an Effector of Transforming Growth Factor β Signaling and Cardiac Remodeling.
Accornero F; van Berlo JH; Correll RN; Elrod JW; Sargent MA; York A; Rabinowitz JE; Leask A; Molkentin JD
Mol Cell Biol; 2015 Jun; 35(12):2154-64. PubMed ID: 25870108
[TBL] [Abstract][Full Text] [Related]
20. Connective tissue growth factor (CCN2) is a matricellular preproprotein controlled by proteolytic activation.
Kaasbøll OJ; Gadicherla AK; Wang JH; Monsen VT; Hagelin EMV; Dong MQ; Attramadal H
J Biol Chem; 2018 Nov; 293(46):17953-17970. PubMed ID: 30262666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
